- Conditions
- Depressive Disorder, Anxiety
- Interventions
- JNJ-42165279, Placebo
- Drug · Other
- Lead sponsor
- Janssen Research & Development, LLC
- Industry
- Eligibility
- 18 Years to 64 Years
- Enrollment
- 161 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2015 – 2019
- U.S. locations
- 8
- States / cities
- Costa Mesa, California • Oceanside, California • Miami, Florida + 5 more
Search Results
Search by objective public record fields.
Search by query text, NCT ID, condition, intervention, sponsor, city, state, recruitment status, phase, study type, healthy volunteer eligibility, sex, or age. Results are retrieved from ClinicalTrials.gov and synchronized into the directory. Search pages remain noindex by default.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Showing 1–5
of 5
matching trials from the live ClinicalTrials.gov search.
Local D1 index available.
- Conditions
- Major Depressive Disorder With Anxious Distress
- Interventions
- JNJ-61393215, Placebo
- Drug
- Lead sponsor
- Janssen Research & Development, LLC
- Industry
- Eligibility
- 18 Years to 64 Years
- Enrollment
- 222 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2019 – 2021
- U.S. locations
- 9
- States / cities
- Garden Grove, California • Alpharetta, Georgia • Atlanta, Georgia + 6 more
- Conditions
- Depressive Disorder, Depression, Depressive Disorder, Major, Mood Disorders, Mental Disorders
- Interventions
- Placebo + ADT, Brexpiprazole +ADT
- Drug
- Lead sponsor
- Otsuka Pharmaceutical Development & Commercialization, Inc.
- Industry
- Eligibility
- 18 Years to 65 Years
- Enrollment
- 837 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2014 – 2016
- U.S. locations
- 30
- States / cities
- Birmingham, Alabama • Beverly Hills, California • Denver, Colorado + 27 more
- Conditions
- Major Depressive Disorder (MDD), Major Depressive Disorder With Anxious Distress
- Interventions
- SPT-300, Placebo
- Drug
- Lead sponsor
- Seaport Therapeutics
- Industry
- Eligibility
- 18 Years to 65 Years
- Enrollment
- 360 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2025 – 2027
- U.S. locations
- 30
- States / cities
- Chino, California • Garden Grove, California • Glendale, California + 26 more
- Conditions
- Major Depressive Disorder (MDD), Major Depressive Disorder With Anxious Distress
- Interventions
- SPT-300
- Drug
- Lead sponsor
- Seaport Therapeutics
- Industry
- Eligibility
- 18 Years to 66 Years
- Enrollment
- 360 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2025 – 2027
- U.S. locations
- 14
- States / cities
- Chino, California • Garden Grove, California • Glendale, California + 11 more